amyloidosis

And I would love you to listen to this podcast and go to your local service and think about what are your blind spots in your service? Where are the barriers? Where are really the bottlenecks of care? Do we have access to echo? Do we have clinics to facilitate uptitration of foundational therapy? Do we have pathways to monitor bloods? And in particular, when it now comes to implementation of MRAs and of course, what are the pathways to develop when it comes to structural valve disease like mitral and tricuspid regurgitation.

Of course, the National Amyloidosis Centre at the core, we have separate podcasts on this and how to refer, now focusing, of course, on heart failure, advanced heart failure, and the referral to the transplant center early, certainly to think about that.

So do go home and think about your services and how you can raise those questions and raise your voice in the MDT.

Share your opinion and concerns, and flag those patients up early.